Sonia Poli
Chief Scientific Officer and Head of Development
drug development
Addex Therapeutics
Switzerland
Biography
Sonia Poli, Chief Scientific Officer and Head of Development Dr. Poli, who joined Addex in 2004, has broad expertise in drug development from lead generation through to entry in man. At Addex she has overseen the transition of multiple products from discovery projects to clinical development programs. She worked from 1997 to 2004 in the drug metabolism and pharmacokinetics (DMPK) area at Roche, where she was a key inventor and global head of a multidimensional optimization approach for drug discovery and development. As a result, she played an important role in selecting clinical candidates in central nervous system (CNS) indications, including Alzheimer’s disease, Parkinson’s disease, bi-polar disorders and anxiety. Dr. Poli obtained her degree and doctorate in Industrial Chemistry at the University of Milan in 1993 and completed a post doctoral fellowship at the CNRS, in Paris, in the group of Prof. D. Mansuy in 1997. Dr. Poli is co-author of more than 25 research publications and patents.
Research Interest
Industrial Chemistry
